Sandoz Group AG
Open
67 -0.15
Overview
Share price change
24h
Min
66.52
Max
67.9
Income | 160M 537M |
|---|---|
Sales | 641M 5.9B |
P/E Sector Avg | 38.795 49.052 |
EPS | 1.238 |
Dividend yield | 1.59 |
Profit margin | 9.093 |
Employees | 22,356 |
EBITDA | 427M 1B |
Recommendations | Buy |
|---|---|
12 Months Forecast | +10.39% upside |
Dividend yield Sector Avg | 1.59% 2.36% |
|---|---|
Next Earnings | 5 sie 2026 |
Market Cap | -1.1B 28B |
|---|---|
Previous open | 67.15 |
Previous close | 67 |
Sandoz Group AG Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
